ReNerve and RMIT awarded $499k grant

Key points

• ReNerve awarded $499k grant from Australian government for nerve regeneration project
• Partnership with RMIT and Associate Professor Shadi Houshyar focuses on using patients' blood to accelerate nerve regeneration
• Potential applications beyond prostate surgery, including nerve cuffs, conduits, and nerve guide matrix

Full summary

ReNerve Limited, an Australian biotechnology company, has been awarded a $498,856 grant from the Commonwealth of Australia through the Department of Education for a nerve regeneration project in partnership with Royal Melbourne Institute of Technology (RMIT) and Associate Professor Shadi Houshyar. The project aims to use patients' own blood to accelerate nerve regeneration post-prostate surgery. The grant funding will be allocated between RMIT and ReNerve according to the approved project budget. The technology could be used with additional tissue products like ReNerve's nerve conduits and nerve guide matrix, with potential applications beyond prostate surgery. The project is currently at the research and development stage.